Does ESKETAMINE Cause Lung neoplasm malignant? 7 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Lung neoplasm malignant have been filed in association with ESKETAMINE (Spravato). This represents 0.1% of all adverse event reports for ESKETAMINE.
7
Reports of Lung neoplasm malignant with ESKETAMINE
0.1%
of all ESKETAMINE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Lung neoplasm malignant From ESKETAMINE?
Of the 7 reports, 1 (14.3%) resulted in death, 1 (14.3%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESKETAMINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ESKETAMINE Cause?
Dissociation (3,103)
Sedation (2,244)
Suicidal ideation (1,254)
Drug ineffective (1,005)
Nausea (807)
Depression (800)
Anxiety (659)
Hospitalisation (657)
Product dose omission issue (635)
Hypertension (605)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which ESKETAMINE Alternatives Have Lower Lung neoplasm malignant Risk?
ESKETAMINE vs ESLICARBAZEPINE
ESKETAMINE vs ESMOLOL
ESKETAMINE vs ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE
ESKETAMINE vs ESOMEPRAZOLE\NAPROXEN